ZURA

Zura Bio Limited - Class A Ordinary shares (ZURA)

About Zura Bio Limited - Class A Ordinary shares (ZURA)

Zura Bio Ltd. is a clinical-stage, multi-asset immunology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Details

Daily high

$5.24

Daily low

$4.74

Price at open

$5.20

52 Week High

$7.44

52 Week Low

$1.88

Market cap

499.3M

Dividend yield

Volume

2.6M

Avg. volume

1.7M

P/E ratio

-4.14

Zura Bio Limited - Class A Ordinary shares News